Discover why Microsoft is a top buy with strong AI-driven growth, rising Azure revenue, and 113% price upside.
Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...
Objectives In patients with chronic obstructive pulmonary disease (COPD), severe exacerbations (ECOPDs) impose significant morbidity and mortality. Current guidelines emphasise using ECOPD history to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback